Urology Times staff
Urology FDA approvals of 2016
Urology-related FDA approvals from 2016 encompassed drugs and devices for prostate cancer, renal cell carcinoma, bladder cancer, stone disease, and more.
Urology Times column earns award for editorial excellence
Urology Times is pleased to announce that the publication’s “Coding and Reimbursement” column has been recognized for editorial excellence by the American Society of Business Publication Editors.
Best of AUA 2013: Bladder Cancer
Edmund Chiong, MD, presents the take home messages on bladder cancer from the AUA annual meeting in San Diego.
Best of AUA 2013: Outcomes Analysis
Danil V. Makarov, MD, MHS, presents the take home messages on outcomes analysis.
Best of AUA 2013: Stone Disease/Endourology
Mantu Gupta, MD, presents the take home messages on stone disease/endourology from the AUA annual meeting in San Diego.
Best of AUA 2013: Penile, Testis, and Urethral Cancer
Harcharan Singh Gill, MD, presents the take home messages on penile, testis, and urethral cancer from the AUA annual meeting in San Diego.
Best of AUA 2013: Kidney Cancer
Andrew Wagner, MD, presents the take home messages on kidney cancer from the AUA annual meeting in San Diego.
Best of AUA 2013: Transplantation/Vascular Surgery
Daniel Shoskes, MD, presents the take home messages on transplantation/vascular surgery from the AUA annual meeting in San Diego.
Best of AUA 2013: Trauma/Reconstruction/Diversion
Hunter Wessells, MD, presents the take home messages on trauma/reconstruction/diversion from the AUA annual meeting in San Diego.
Best of AUA 2013: Minimally Invasive Surgery
James Brown, MD, presents the take home messages on minimally invasive surgery from the AUA annual meeting in San Diego.

Poll

View Results